Ingalls Health System
Harvey, Illinois 60426
0 studies enrolling now · 1 studies all time
What they study most
Lung Cancer
Studies at this site
A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks
— Completed